Plavix

New guidelines for knee and hip replacements issued

October 03, 2011

New clinical treatment guidelines for preventing blood clots after hip or knee replacements emphasize preventive measures and caution against post-operative ultrasound tests.
 

FDA places black-box warning on blood thinner Plavix

March 15, 2010

The Food and Drug Administration Friday placed a black-box warning—its most severe safety labeling—on the blood thinner Plavix. In a statement, it said that the drug could put certain patients at increased risk for heart attack and stroke.